This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sigmon, D. H. Articles by Beierwaltes, W. H. Search for Related Content PubMed PubMed Citation Articles by Sigmon, D. H. Articles by Beierwaltes, W. H.

(Hypertension. 1995;25:803-808.)
© 1995 American Heart Association, Inc.

Articles

Endothelium-Derived Constricting Factor in Renovascular Hypertension

David H. Sigmon; William H. Beierwaltes

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich.

Abstract We have reported that in two-kidney, one clip hypertensive rats, renal perfusion is maintained by a balance between the vasodilator endothelium-derived nitric oxide and the vasoconstrictor angiotensin II. Others have suggested that endothelium-derived constricting factor, reported to be thromboxane A₂ and/or endoperoxide, contributes to increased blood pressure in angiotensin II–dependent hypertension. We hypothesized that in angiotensin II–dependent two-kidney, one clip hypertension, endothelium-derived constricting factor contributes to vasoconstriction of the clipped kidney following nitric oxide synthesis inhibition. Using radioactive microspheres, we studied renal blood flow to the stenotic kidney of two-kidney, one clip hypertensive rats 4 weeks after clipping. The influence of nitric oxide on systemic and renal hemodynamics was evaluated by determining the response to nitric oxide synthesis inhibition using 10 mg/kg N-nitro-L-arginine methyl ester in these rats, which were either not treated (n=8) or treated (n=8) with 4 mg/kg of the constricting factor receptor antagonist BMS 180,291. Mean basal blood pressure in rats was 167±9 mm Hg (mean±SEM). N-Nitro-L-arginine methyl ester increased blood pressure by 35±7 mm Hg (P<.001). In the clipped kidney, N-nitro-L-arginine methyl ester decreased renal blood flow by 40% (from 4.5±0.9 to 2.7±0.6 mL · min^-1 · g kidney^-1; P<.01) and increased renal vascular resistance by 100% (from 51.9±9.6 to 105.0±19.2 mm Hg · mL^-1 · min^-1 · g kidney^-1; P<.005). Pretreatment with BMS 180,291 had no effect on basal blood pressure (167±7 mm Hg) or blood flow to the clipped kidney. However, constricting factor blockade diminished the pressor response to N-nitro-L-arginine methyl ester by 63%, decreasing the response to only 13±4 mm Hg (P<.02). In rats treated with BMS 180,291, N-nitro-L-arginine methyl ester decreased blood flow to the clipped kidney by only 12% (from 5.4±0.6 to 4.7±0.5 mL · min^-1 · g kidney^-1; P<.05), while renal vascular resistance increased by only 17% (from 36.7±7.1 to 43.0±7.2 mm Hg · mL^-1 · min^-1 · g kidney^-1; P<.005). In conclusion, although blocking endothelium-derived constricting factor in hypertensive rats affected neither basal blood pressure nor renal blood flow, it dramatically blunted both the systemic pressor and renal constrictor responses to inhibition of endothelium-derived nitric oxide synthesis. These data suggest a significant regulatory interaction between endothelium-derived constricting factor and endothelium-derived nitric oxide in renovascular hypertension.

Key Words: nitric oxide • hypertension, renovascular • thromboxanes • angiotensin II • renal circulation

This article has been cited by other articles:

				O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867. [Abstract] [Full Text] [PDF]

				D. H. Sigmon and W. H. Beierwaltes Influence of Nitric Oxide in the Chronic Phase of Two-Kidney, One Clip Renovascular Hypertension Hypertension, February 1, 1998; 31(2): 649 - 656. [Abstract] [Full Text] [PDF]

				H. Guan, V. Cachofeiro, M. L. Pucci, P. M. Kaminski, M. S. Wolin, and A. Nasjletti Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension Hypertension, January 1, 1996; 27(1): 19 - 24. [Abstract] [Full Text]